WOLFGANG WINKELMAYER to Dipeptidyl-Peptidase IV Inhibitors
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Dipeptidyl-Peptidase IV Inhibitors.
Connection Strength
0.210
-
Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease. Diabetes Obes Metab. 2022 05; 24(5):928-937.
Score: 0.210